LON:GSK - GlaxoSmithKline Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 1,524.60 +21.40 (+1.42 %) (As of 03/21/2019 02:20 AM ET)Previous CloseGBX 1,503.20Today's RangeGBX 1,504.60 - GBX 1,532.6052-Week RangeGBX 1,269.80 - GBX 1,648.80Volume7.88 million shsAverage Volume9.12 million shsMarket Capitalization£75.01 billionP/E Ratio20.91Dividend Yield6.10%BetaN/A ProfileDiscussionAnalyst RatingsChartDividendEarningsInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom. Receive GSK News and Ratings via Email Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolLON:GSK Previous Symbol CUSIPN/A CIKN/A Webwww.gsk.com Phone+44-20-80475000Debt Debt-to-Equity Ratio709.80 Current Ratio0.75 Quick Ratio0.47Price-To-Earnings Trailing P/E Ratio20.91 Forward P/E Ratio0.13 P/E GrowthN/A Sales & Book Value Annual Sales£30.82 billion Price / Sales2.43 Cash FlowGBX 93.21 per share Price / Cash Flow16.36 Book ValueGBX 88.60 per share Price / Book17.21Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares4,919,989,760Market Cap£75.01 billion Next Earnings Date5/1/2019 (Estimated) OptionableOptionable GlaxoSmithKline (LON:GSK) Frequently Asked Questions What is GlaxoSmithKline's stock symbol? GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK." How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline? GlaxoSmithKline declared a dividend on Wednesday, February 6th. Shareholders of record on Thursday, February 21st will be paid a dividend of GBX 23 per share on Thursday, April 11th. This represents a yield of 1.49%. The ex-dividend date is Thursday, February 21st. This is an increase from GlaxoSmithKline's previous dividend of $19.00. The official announcement can be seen at this link. View GlaxoSmithKline's Dividend History. How were GlaxoSmithKline's earnings last quarter? GlaxoSmithKline plc (LON:GSK) released its earnings results on Wednesday, April, 25th. The company reported $24.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $24.30 by $0.30. View GlaxoSmithKline's Earnings History. When is GlaxoSmithKline's next earnings date? GlaxoSmithKline is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for GlaxoSmithKline. What price target have analysts set for GSK? 18 analysts have issued twelve-month price objectives for GlaxoSmithKline's stock. Their forecasts range from GBX 41.74 to GBX 1,900. On average, they anticipate GlaxoSmithKline's stock price to reach GBX 1,518.15 in the next twelve months. This suggests that the stock has a possible downside of 0.4%. View Analyst Price Targets for GlaxoSmithKline. What is the consensus analysts' recommendation for GlaxoSmithKline? 18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 2 sell ratings, 11 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline. Has GlaxoSmithKline been receiving favorable news coverage? Headlines about GSK stock have been trending somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. GlaxoSmithKline earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. Who are some of GlaxoSmithKline's key competitors? Some companies that are related to GlaxoSmithKline include AstraZeneca (AZN), Bayer (BAYN), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Medical Developments (MVP), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS), Futura Medical (FUM) and Cathay International (CTI). What other stocks do shareholders of GlaxoSmithKline own? Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include General Electric (GE), Intel (INTC), Lloyds Banking Group (LLOY), Vodafone Group (VOD), Bank of America (BAC), AstraZeneca (AZN), BP (BP), AT&T (T), Pfizer (PFE) and Johnson & Johnson (JNJ). Who are GlaxoSmithKline's key executives? GlaxoSmithKline's management team includes the folowing people: Ms. Emma Walmsley, CEO & Director (Age 49)Mr. Simon P. Dingemans, CFO & Exec. Director (Age 55)Mr. Jack Bailey, Pres of US PharmaceuticalsMs. Karenann K. Terrell, Chief Digital & Technology Officer (Age 58)Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56) How do I buy shares of GlaxoSmithKline? Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is GlaxoSmithKline's stock price today? One share of GSK stock can currently be purchased for approximately GBX 1,524.60. How big of a company is GlaxoSmithKline? GlaxoSmithKline has a market capitalization of £75.01 billion and generates £30.82 billion in revenue each year. What is GlaxoSmithKline's official website? The official website for GlaxoSmithKline is http://www.gsk.com/. How can I contact GlaxoSmithKline? GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000. MarketBeat Community Rating for GlaxoSmithKline (LON GSK)Community Ranking: 1.9 out of 5 ()Outperform Votes: 881 (Vote Outperform)Underperform Votes: 1,427 (Vote Underperform)Total Votes: 2,308MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/21/2019 by MarketBeat.com StaffFeatured Article: Why is the ROA ratio important?